Illumina Inc (ILMN)
130.12
-2.15
(-1.63%)
USD |
NASDAQ |
Sep 27, 16:00
130.10
-0.02
(-0.02%)
After-Hours: 20:00
Illumina SG&A Expense (Annual): 1.612B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 1.612B |
December 31, 2022 | 1.297B |
December 31, 2021 | 2.092B |
December 31, 2020 | 941.00M |
December 31, 2019 | 835.00M |
December 31, 2018 | 794.00M |
December 31, 2017 | 674.00M |
December 31, 2016 | 584.00M |
December 31, 2015 | 516.00M |
December 31, 2014 | 466.28M |
December 31, 2013 | 381.04M |
December 31, 2012 | 285.99M |
December 31, 2011 | 261.84M |
Date | Value |
---|---|
December 31, 2010 | 220.45M |
December 31, 2009 | 176.34M |
December 31, 2008 | 148.01M |
December 31, 2007 | 101.26M |
December 31, 2006 | 54.06M |
December 31, 2005 | 27.97M |
December 31, 2004 | 25.08M |
December 31, 2003 | 18.90M |
December 31, 2002 | 9.099M |
December 31, 2001 | 5.663M |
December 31, 2000 | 4.193M |
December 31, 1999 | 1.349M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
835.00M
Minimum
2019
2.092B
Maximum
2021
1.355B
Average
1.297B
Median
2022
SG&A Expense (Annual) Benchmarks
Waters Corp | 736.01M |
Exact Sciences Corp | 1.620B |
Mettler-Toledo International Inc | 904.11M |
Guardant Health Inc | 451.03M |
Natera Inc | 618.31M |